Steven B. Ketchum, Chief Scientific Officer at AMARIN CORP PLC\UK (AMRN), sold 864,793 shares at $8.01 ($6.9M) on 2021-01-27, disclosed to the SEC on 2021-01-29.
Open-market sale of $6.9M AMRN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.01 | 143,392 | $1.1M | 16.6% |
| 2 | $8.01 | 143,392 | $1.1M | 16.6% |
| 3 | $8.01 | 278,237 | $2.2M | 32.2% |
| 4 | $8.01 | 278,237 | $2.2M | 32.2% |
| 5 | $7.50 | 1,564 | $12K | 0.2% |
| 6 | $7.50 | 19,971 |
| $150K |
| 2.2% |
| Total | $8.00 avg | 864,793 | $6.9M | 100% |
| Filing → |
| AMRN | SELL | 2019-05-02 | $356K | — | Filing → |
| AMRN | SELL | 2019-04-01 | $381K | — | Filing → |
| AMRN | SELL | 2019-03-01 | $2.4M | — | Filing → |